中性粒细胞/淋巴细胞比值在肾细胞癌中的研究进展  

Progress of neutrophil to lymphocyte ratio in renal cell carcinoma

作　　者：赵仁杰 谭智勇 付什 张荣 王剑松[1] 王海峰 ZHAO Renjie;TAN Zhiyong;FU Shi;ZHANG Rong;WANG Jiansong;WANG Haifeng(Department of Urology,Second Affiliated Hospital of Kunming Medical University,Kunming,650101,China;Department of Urology,People's Hospital of Xishuangbanna Dai Autonomous Prefecture)

机构地区：[1]昆明医科大学第二附属医院泌尿外科,昆明650101 [2]西双版纳傣族自治州人民医院泌尿外科

出　　处：《临床泌尿外科杂志》2024年第9期844-848,共5页Journal of Clinical Urology

摘　　要：炎症反应是恶性肿瘤发生、发展和转移的重要因素。中性粒细胞与淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)与肾细胞癌患者的预后密切相关,且已被证实可以预测各种实体瘤的结果。本文就NLR在肾细胞癌中的研究进展进行综述,旨在更好地预测肾细胞癌预后及指导治疗决策。Inflammation is an important factor in the occurrence,development and metastasis of malignant tumors.Neutrophil to lymphocyte ratio(NLR)is closely related to the prognosis of patients with renal cell carcinoma and has been proved to be able to predict the outcome of various solid tumors.This article reviews the research progress of NLR in renal cell carcinoma,in order to better predict the prognosis and guide the treatment decision of renal cell carcinoma.

关 键 词：中性粒细胞/淋巴细胞比值 肾细胞癌 预后 

分 类 号：R737.11[医药卫生—肿瘤]